JP2008500337A5 - - Google Patents

Download PDF

Info

Publication number
JP2008500337A5
JP2008500337A5 JP2007514981A JP2007514981A JP2008500337A5 JP 2008500337 A5 JP2008500337 A5 JP 2008500337A5 JP 2007514981 A JP2007514981 A JP 2007514981A JP 2007514981 A JP2007514981 A JP 2007514981A JP 2008500337 A5 JP2008500337 A5 JP 2008500337A5
Authority
JP
Japan
Prior art keywords
amino
carbonyl
alkyl
phenyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007514981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500337A (ja
Filing date
Publication date
Priority claimed from SE0401342A external-priority patent/SE0401342D0/xx
Application filed filed Critical
Publication of JP2008500337A publication Critical patent/JP2008500337A/ja
Publication of JP2008500337A5 publication Critical patent/JP2008500337A5/ja
Abandoned legal-status Critical Current

Links

JP2007514981A 2004-05-25 2005-05-20 治療化合物 Abandoned JP2008500337A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401342A SE0401342D0 (sv) 2004-05-25 2004-05-25 Therapeutic compounds
PCT/SE2005/000754 WO2005115972A1 (en) 2004-05-25 2005-05-20 Therapeutic compounds

Publications (2)

Publication Number Publication Date
JP2008500337A JP2008500337A (ja) 2008-01-10
JP2008500337A5 true JP2008500337A5 (enExample) 2008-05-08

Family

ID=32589801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007514981A Abandoned JP2008500337A (ja) 2004-05-25 2005-05-20 治療化合物

Country Status (16)

Country Link
US (1) US20090018116A1 (enExample)
EP (1) EP1756044A1 (enExample)
JP (1) JP2008500337A (enExample)
CN (1) CN1989100A (enExample)
AR (1) AR049898A1 (enExample)
AU (1) AU2005247835A1 (enExample)
BR (1) BRPI0511532A (enExample)
CA (1) CA2565066A1 (enExample)
IL (1) IL179145A0 (enExample)
MX (1) MXPA06013536A (enExample)
NO (1) NO20065904L (enExample)
SE (1) SE0401342D0 (enExample)
TW (1) TW200539856A (enExample)
UY (1) UY28922A1 (enExample)
WO (1) WO2005115972A1 (enExample)
ZA (1) ZA200609542B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2024349B1 (en) 2006-05-31 2017-08-02 AbbVie Inc. Compounds as cannabinoid receptor ligands and uses thereof
US8841334B2 (en) 2006-05-31 2014-09-23 Abbvie Inc. Compounds as cannabinoid receptor ligands and uses thereof
CN101765594A (zh) 2007-03-28 2010-06-30 雅培制药有限公司 作为大麻素受体配体的1,3-噻唑-2(3h)-亚基化合物
US7872033B2 (en) 2007-04-17 2011-01-18 Abbott Laboratories Compounds as cannabinoid receptor ligands
JP2010527929A (ja) 2007-05-18 2010-08-19 アボット・ラボラトリーズ カンナビノイド受容体リガンドとしての新規な化合物
US8338623B2 (en) * 2007-07-09 2012-12-25 Abbvie Inc. Compounds as cannabinoid receptor ligands
US9193713B2 (en) 2007-10-12 2015-11-24 Abbvie Inc. Compounds as cannabinoid receptor ligands
AU2009203549B2 (en) * 2008-01-08 2013-03-07 Purdue Pharma L.P. Proline Analogs as ligands for cannabinoid receptors for the treatment of pain
US8846730B2 (en) 2008-09-08 2014-09-30 Abbvie Inc. Compounds as cannabinoid receptor ligands
GB2463318A (en) * 2008-09-12 2010-03-17 Syngenta Participations Ag Preparation of anthranilamide derivatives containing a pyridinylpyrazole moiety
US8859596B2 (en) 2008-09-16 2014-10-14 Abbvie Inc. Compounds as cannabinoid receptor ligands
PA8854001A1 (es) 2008-12-16 2010-07-27 Abbott Lab Compuestos novedosos como ligandos de receptores de canabinoides
PL2864291T3 (pl) 2012-06-26 2017-07-31 Bayer Pharma Aktiengesellschaft N-[4-(chinolin-4-yloksy)cykloheksylo(metylo)](hetero)arylokarboksyamidy jako antagoniści receptora androgenowego, ich wytwarzanie i zastosowanie jako produktów medycznych
KR20140011780A (ko) * 2012-07-19 2014-01-29 한미약품 주식회사 단백질 키나아제 저해활성을 갖는 이소퀴놀린-5-카복스아미드 유도체
KR20150090219A (ko) * 2012-12-06 2015-08-05 바루크 에스. 블럼버그 인스티튜트 Hbv 감염에 대항하여 항바이러스 물질로써 기능화된 벤자미드 유도체들
GB201313664D0 (en) * 2013-07-31 2013-09-11 Univ Cardiff Bcl-3 inhibitors
US10273218B2 (en) * 2014-07-31 2019-04-30 University College Cardiff Consultants Limited BCL-3 inhibitors
SG11201700777VA (en) 2014-08-04 2017-02-27 Nuevolution As Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
US9732061B2 (en) 2015-01-12 2017-08-15 Janssen Pharmaceutica Nv Cinnoline derivatives useful as CB-1 receptor inverse agonists
EP3307725A1 (en) 2015-06-11 2018-04-18 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
CA3093189A1 (en) 2018-03-07 2019-09-12 Bayer Aktiengesellschaft Identification and use of erk5 inhibitors
WO2020234103A1 (en) 2019-05-21 2020-11-26 Bayer Aktiengesellschaft Identification and use of kras inhibitors
US12187681B2 (en) 2019-12-14 2025-01-07 Shanghai East Hospital Ion channel antagonists/blockers and uses thereof
US11447479B2 (en) 2019-12-20 2022-09-20 Nuevolution A/S Compounds active towards nuclear receptors
TWI872177B (zh) 2019-12-20 2025-02-11 丹麥商紐韋盧森公司 對核受體具有活性之化合物
WO2021152113A1 (en) 2020-01-31 2021-08-05 Bayer Aktiengesellschaft Substituted 2,3-benzodiazepines derivatives
CA3174176A1 (en) 2020-03-31 2021-10-07 Sanne Schroder Glad Compounds active towards nuclear receptors
JP7713953B2 (ja) 2020-03-31 2025-07-28 ヌエヴォリューション・アクティーゼルスカブ 核内受容体に対して活性な化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0054132B1 (de) * 1980-12-12 1984-10-10 Dr. Karl Thomae GmbH Neue Pyrimidinone, ihre Herstellung und Arzneimittel mit einem Gehalt an diesen Stoffen
WO1991005549A1 (en) * 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
DE19648793A1 (de) * 1996-11-26 1998-05-28 Basf Ag Neue Benzamide und deren Anwendung
MY138097A (en) * 2000-03-22 2009-04-30 Du Pont Insecticidal anthranilamides
US7160878B2 (en) * 2000-07-27 2007-01-09 Eli Lilly And Company Substituted heterocyclic amides
EP1383799A4 (en) * 2001-04-10 2008-08-06 Transtech Pharma Inc PROBES, SYSTEMS AND METHODS FOR DISCOVERING MEDICAMENTS
GB0222493D0 (en) * 2002-09-27 2002-11-06 Glaxo Group Ltd Compounds
US20060089398A1 (en) * 2003-03-19 2006-04-27 Gang Liu Isoxazole carboxamide derivatives as ghrelin receptor modulators

Similar Documents

Publication Publication Date Title
JP2008500337A5 (enExample)
RU2595902C2 (ru) Замещенные бензамидные производные
RU2709207C2 (ru) 1,3,4-оксадиазольные производные соединения в качестве ингибитора гистондеацетилазы 6 и фармацевтическая композиция, содержащая их
AU2004281215B2 (en) Derivatives of N-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
RU2475487C2 (ru) Имидазохинолины с иммуномодулирующими свойствами
ES2423851T3 (es) Compuesto de aciltiourea o sal del mismo y uso del mismo
JP5580741B2 (ja) 含窒素複素環化合物およびその用途
TWI450893B (zh) Inhibition of prostaglandin D synthase in the piper Compounds
JPWO2004046110A1 (ja) メラニン凝集ホルモン受容体拮抗剤
US20090018116A1 (en) Therapeutic Compounds
NZ614305A (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
US20070010529A1 (en) Nitrogenous heterocyclic compounds and medical use thereof
US8012981B2 (en) Benzylpiperazine derivatives as motilin receptor agonists
JPWO2006030975A1 (ja) ピペリジン誘導体およびその用途
RU2009138219A (ru) Новые бензамидные производные и способ их получения
JP2005526797A (ja) ケモカイン受容体活性(特にccr5)のモジュレーターとして有用なピペリジンまたは8−アザ−ビシクロ[3.2.1]オクタ−3−イル誘導体
NZ552501A (en) Novel cyclic aminobenzoic acid derivative
JP2014506905A (ja) 新規なベンゾジオキソールピペリジン化合物
NO20084674L (no) 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser
JP2010506910A5 (enExample)
US20080275085A1 (en) Piperidine derivative and use thereof
ES2286474T3 (es) Derivados de 4-(finilpiperazinilmetil) benzamida y su uso para el tratamiento de dolor o transtornos gastrointestinales.
US20100179118A1 (en) Cyclic aminoalkylcarboxamide derivative
ES2390812T3 (es) Derivados de bencilpiperazina útiles para el tratamiento de trastornos gastrointestinales
JP2008500335A5 (enExample)